You are here

  • Home
  • Archive
  • Volume 16, Issue 4
  • Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes

Authors

  1. Correspondence to Yves Lacourcière
    2705 Laurier Boulevard, Quebec, QC G1V 4G2, Canada; yves.lacourciere{at}crchul.ulaval.ca
View Full Text

Citation

Lacourcière Y, Poirier L
Valsartan is more effective than placebo in reducing the incidence of diabetes in people with impaired glucose tolerance and cardiovascular disease or risk factors but has no effect on cardiovascular outcomes
BMJ Evidence-Based Medicine 2011;16:122-123.

Publication history

  • First published June 6, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions